Here's why EML (ASX:EML) shares have surged 33% this week

It has been a great week for the payment solution company's share price.

| More on:
Man puts thumb up next to stock market graph

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in EML Payments Ltd (ASX: EML) took off in a vertical fashion yesterday after the payments solutions provider confirmed an end to its investigation with the Central Bank of Ireland (CBI).

EML shares were on the down this week just prior to the announcement. They have reversed course over the past 2 days and now trade 32% higher at $3.62. Investors are piling in today as well, with today's trading volume at 144% of their 4-week average volume so far.

Here are more details.

Go ahead, EML, do your thing

In the update, EML advised that the CBI has given the green light for it to establish a base and start signing customers in Ireland.

EML's subsidiary, PFS Card Services (Ireland) Limited (PCSIL) was under the Irish regulator's microscope after it voiced regulatory concerns with the company back in May.

At the time of the announcement, investors punished EML, wiping around half its value off the table in the days afterwards. Its share price had yet to make a recovery – until yesterday's sprout from the soil of its 52-week lows.

Another positive from the CBI's ruling is that no controls are set to be imposed on any of PCSIL's new programs. The subsidiary has also agreed to work with the regulator and ensure all compliance measures are met with certainty.

One limit that was imposed, however, was a growth cap on PCSIL's total payment volumes. The growth limitation will be in place for a year but could be removed beforehand if PCSIL verifies it is complying with all relevant measures.

The EML share price was catching bids like feeding tuna yesterday, as investors sent its share price flying from a low of $2.75 to close at $3.61.

The frenzy has since cooled off somewhat today, however shares are now up 18% on the month, and are starting to claw back some gains from the longer-term downtrend.

For comparison, just prior to the CBI's investigation which started in May, EML had just reclaimed its losses from the March 2020 selloff, brought on by COVID-19. Back then it was posting record highs again, right before the news broke.

However, yesterday's update has commentary shifting back to a more bullish tone. A recent note out of UBS updating its clients suggests that there is more life in the EML share price.

The broker retained its buy rating in the note and values EML at $4.40 per share following the update out of EML's corner.

UBS reckons that the go ahead improves EML's company risk profile, which in turn improves the risk and reward prospects for investors. The firm also believes it could re-rate at higher multiples in the future if European profits are high.

EML share price snapshot

These gains are welcomed for the EML share price, having posted a loss of just 1% in the past 12 months now. Despite this, it is still down 13% this year to date.

After wiping half of its value back in May, the EML share price was trading flat until October, where it began losing popularity.

It reached a 52-week closing low on 23 November, just before the CBI's resolutions were announced, which sent EML shares back north.

The author has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended EML Payments. The Motley Fool Australia owns shares of and has recommended EML Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »